Literature DB >> 3480069

Lymphocyte subsets, natural killer cytotoxicity, and perioperative blood transfusion for elective colorectal cancer surgery.

P I Tartter1, G Martinelli.   

Abstract

Blood transfusions are associated with phenomena attributable to immune suppression. Since perioperative blood transfusion is associated with early cancer recurrence in patients with malignancies, we prospectively studied T-cell subsets and natural killer cytotoxicity in patients undergoing potentially curative surgery for colorectal cancer. Preoperative total peripheral lymphocyte number was significantly (P = 0.0191) depressed in patients who were subsequently transfused, but returned to normal by follow-up 1 to 3 months after surgery. Natural killer cytotoxicity declined significantly (P less than 0.05) at follow-up in patients who were not transfused. These results do not explain the association of blood transfusion with cancer recurrence observed in colorectal cancer patients. Blood transfusion in this study was followed by increased numbers of peripheral lymphocytes and higher natural killer cytotoxicity.

Entities:  

Mesh:

Year:  1987        PMID: 3480069

Source DB:  PubMed          Journal:  Cancer Detect Prev Suppl        ISSN: 1043-6995


  3 in total

1.  Safety and efficacy of early postoperative hyperbaric oxygen therapy with restriction of transfusions in patients with HCC who have undergone partial hepatectomy.

Authors:  Shinichi Ueno; Masahiko Sakoda; Hiroshi Kurahara; Satoshi Iino; Koji Minami; Kei Ando; Yukou Mataki; Kosei Maemura; Sumiya Ishigami; Hiroyuki Shinchi; Shoji Natsugoe
Journal:  Langenbecks Arch Surg       Date:  2010-11-11       Impact factor: 3.445

2.  The association of perioperative blood transfusion with colorectal cancer recurrence.

Authors:  P I Tartter
Journal:  Ann Surg       Date:  1992-12       Impact factor: 12.969

Review 3.  Perioperative blood transfusions for the recurrence of colorectal cancer.

Authors:  A Amato; M Pescatori
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.